Why Moderna's Canada Booster Win Is Important
Many investors focus mainly on Moderna's (NASDAQ: MRNA) opportunities in the U.S. and Europe. However, the company markets its COVID-19 vaccine Spikevax in lots of other countries, notably including Canada.
Last month, Canadian regulators granted Emergency Use Authorization to Spikevax for all adults ages 18 and older. In this Motley Fool Live video recorded on Nov. 16, 2021, Motley Fool contributors Keith Speights and Brian Orelli discuss how important this Canadian booster authorization is for Moderna. (Note: This video was recorded prior to the U.S. extending authorization for Moderna's vaccine to all adults.)
Source Fool.com
